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Ralstonia mannitolilytica is a nonfermentative, Gram-negative bacterium isolated infrequently from clinical samples. The novel genus Ralstonia includes 
three main pathogenic species: Ralstonia pickettii, Roseomonas 
gilardii, and Roseomonas basiliensis [1]. R. pickettii biovar 
3/“thomassii” was shown to represent a separate species, 
R. mannitolilytica [2]. It is widely distributed in nature, being 
a frequent contaminant in water supplies. It is increasingly 
identified as an opportunistic pathogen in nosocomial 
infections [3,4], especially among immunosuppressed 
patients [5]. It has also been implicated in common source 
nosocomial infection outbreaks due to the addition of 
contaminated water to parenteral fluids [6] and to medical 
equipment presumed to be sterile.
True bacteremia with the organism, however, cannot be ruled 
out, especially if it is isolated repeatedly from the same patient 
within 3 successive days from blood cultures.
CASE REPORT
A 22-year-old Ethiopian male presented to us in December 2015 
with fever with chills and rigor, vomiting, and headache. He was a 
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known end-stage renal disease patient on thrice /week hemodialysis 
through a tunneled hemodialysis catheter for the past 1 year.
His significant medical history includes appendicitis requiring 
emergency admission for surgery at a nearby multispeciality 
hospital in October 2015.
Physical examination revealed mild pedal edema, temperature 
100°F, and pulse 96/min with a blood pressure of 150/86 mm 
of Hg. There was no other remarkable finding in the general 
examination. His systemic examination revealed no other 
important finding except a tender epigastrium.
He had an episode of catheter-related bloodstream infection 
(CRBSI) in October-November 2015 and was treated at a 
multispecialty hospital with parenteral antibiotics (piperacillin-
tazobactam) for 2 weeks (for growth of Pseudomonas aeruginosa 
in blood cultures) during the same admission phase. The tunneled 
catheter was not removed then and lock therapy was used and the 
patient improved gradually with antibiotics.
Recent investigations done during the present admission 
revealed a total leukocyte count of 20,000 cells/mm3 with a 
neutrophilic preponderance, hemoglobin 9.3 g/dl, urea 60 mg/dl, 
creatinine 6.3 mg/dl, sodium 141meq/l, potassium 4.7 meq/l, ALT 
24 U/l, and alkaline phosphatase 114 U/l total protein 10.1 g/dl
Three blood culture sets (aerobic and anaerobic), one set from 
the dialysis line and two from the peripheral lines were submitted 
to microbiology laboratory. Blood cultures (one bottle from each 
of the three sets) flagged positive. The blood culture sent from 
the hemodialysis line was the first to flag positive 12 h after it 
was loaded onto the BACTEC 9050 system. This was followed 
by the aerobic and anaerobic bottles from the peripheral lines. 
The preliminary Gram-stain showed Gram-negative bacilli and 
the cultures grew Gram-negative organisms. The organism was 
identified as R. mannitolilytica by the Vitek 2C. Disc diffusion 
(CLSI 2015) was done for the various antibiotics, and there was 
a 6 mm resistant zone for the following panel tested: Gentamicin, 
cotrimoxazole, aztreonam, amikacin, ceftriaxone, cefotaxime, 
cefepime, ceftazidime, and carbapenems. The organism was 
intermediate to piperacillin-tazobactam (17 mm) and was 
sensitive to and cefoperazone-sulbactum (23 mm).
The patient was on piperacillin-tazobactam (4.5 g intravenous 
[IV] BD) initially, but the fever spikes were persisting. His fever 
decreased and he became afebrile after a change of therapy to 
cefoperazone-sulbactum (3 g of cefoperazone and 1 g of sulbactum/
day in two divided doses) in accordance with the microbiology 
antibiotic sensitivity report. The patient responded well to the 
therapy (for 3 weeks) and was discharged in a hemodynamically 
stable condition with the tunneled catheter.
DISCUSSION
A limited number of cases of hospital outbreaks with R. pickettii 
biovar 3/“thomasii”, i.e., R. mannitolilytica isolates have 
been reported in the literature. The first report [7] dealt with 
bacteremia due to parenteral fluids prepared with deionized 
water contaminated with “P. thomasii”. An epidemic of 
R. pickettii involving 24 patients caused by contaminated saline 
solution was reported [8]. Although no serious outbreaks related 
to R. mannitolilytica have been reported, so far the clinical 
importance of R. mannitolilytica may have been overlooked, 
possibly due to misidentification [8]. Most of these isolates are 
usually misdiagnosed as P. aeruginosa [9]. Our patient too had 
a previous hospitalization for CRBSI due to P. aeruginosa and 
it is quite possible that it could have been R. mannitolilytica 
misidentified as Pseudomonas. We, however, did not have the 
documents from the previous hospital and the susceptibility 
report of Pseudomonas was not available.
Our report is similar to the case setting reported by 
Gröbner et al. On monoclonal outbreak of catheter-related true 
bacteremia [10] due to R. mannitolilytica in hematology patients.
In our case, the organism isolated was unlikely to be a 
contaminant since it was isolated thrice on 3 consecutive days 
from the patient having the same antibiotic sensitivity pattern. 
Moreover, the patient responded dramatically when he was 
treated with the appropriate antibiotic in accordance with the 
sensitivity pattern. No possibilities could be hypothesized 
regarding the probable source of infection and the portal of entry 
for R. mannitolilytica in this patient as the patient presented to us 
for the first time and was getting hemodialysis from some other 
center till then. One potential portal of entry could be the water 
used for preparing dialysate solutions.
This case shows that R. mannitolilytica may be a more 
virulent pathogen than previously believed. Although no serious 
nonoutbreak-related infections have been described thus far, 
the clinical importance of R. mannitolilytica may have been 
overlooked, possibly due to misidentification as Pseudomonas 
fluorescens, Burkholderia multivorans, and/or R. pickettii, which 
are most often treated as contaminant [8]. Therefore, correct 
identification of this organism is of great importance, especially 
so in renal disease patients.
There have not been much reports of R. mannitolilytica 
bacteremia from India. The first of such reports was by 
Mukhopadhyay et al. [9] of a case of R. mannitolilytica in a 
post renal transplant patient. To the best of our knowledge, this 
is the first instance of reported R. mannitolilytica bacteremia in 
a hemodialysis patient with a CRBSI. We report our first case 
of R. mannitolilytica true bacteremia, in a dialysis patient with 
a tunneled catheter, in our newly opened hospital in South India 
where the patient was symptomatic because of the presence of 
this pathogen. Moreover, it was discharged in a stable condition 
after initiation of therapy.
Some limitations of the study were we could not gather correct 
information on whether the patient manipulated the dialysis line 
earlier (H/O IV drug abuse), and whether he maintained the long-
term catheter with strict aseptic measures. The prior susceptibility 
reports could not be collected from the patient.
CONCLUSION
In our set up, this was the first case of R. mannitolilytica 
isolated as a significant pathogen in a case of true bacteremia. 
R. mannitolilytica can thus cause true bacteremia as well in 
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addition to just being an environmental contaminant. Early 
recognition of the infection helps in instituting appropriate 
antibiotic with complete resolution of the infection. In our case 
report, the prompt report of microbiology department enabled us 
to treat the patient on time with appropriate antibiotic and also 
prevented the premature removal of the tunneled catheter.
Currently, there are no clear treatment guidelines or CLSI 
breakpoints for identifying R. mannitolilytica infections. In the 
course of treatment, drug-susceptibility testing to adjust the use 
of antimicrobial agentsis advocated. In addition, cotrimoxazole, 
ceftriaxone, and piperacillin/tazobactam are recommended for 
empirical treatment. Microbiological-detection personnel should 
pay attention to the slow growth of this bacterium. It is suggested 
that the growth condition should be determined after 48 h of 
culturing; otherwise, a missed diagnosis is likely to occur. The 
problems caused by this bacterium occur rapidly and disease 
progression is fast; therefore, R. mannitolilytica infections should 
draw sufficient attention from clinical physicians and bacteriology 
workers to respond to the resulting severe consequences.
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